Advertisement
Advertisement
TSHA
Taysha Gene Therapies, Inc. Common Stock
4.28
USDSponsored
-0.09
-2.17%
Nov 10, 15:59 UTC -5
Closed
After-Market
4.27
-0.01
-0.12%
Taysha Gene Therapies, Inc. Common Stock (TSHA)
Taysha Gene Therapies, Inc. Common Stock Financial Snapshot
| Market Cap | 1.39B |
| Beta | 1.36 |
| Earnings Per Share (EPS) | -0.42 |
| Price-to-Book (P/B) Ratio | 3.24 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 12.72% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -56.19% |
| Current Ratio | 17.76% |
| Free Cash Flow | -81.33M |
